triamterene has been researched along with oxprenolol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Bautier, P; Corvol, P; Ménard, J; Plouin, PF; Serrurier, D | 1 |
| Backhouse, CI; Rowley-Jones, D; Spencer-Mills, L | 1 |
| Gerc, V; Numić, N | 1 |
3 trial(s) available for triamterene and oxprenolol
| Article | Year |
|---|---|
Crossover design to test antihypertensive drugs with self-recorded blood pressure.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Random Allocation; Research Design; Triamterene | 1988 |
Hydrochlorothiazide and triamterene with sustained-release oxprenolol in the treatment of hypertension.
Topics: Aged; Creatinine; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney Function Tests; Male; Middle Aged; Oxprenolol; Potassium; Random Allocation; Triamterene; Urea; Uric Acid | 1986 |
[Use of oxprenolol, triamterene, and dihydralazine in the treatment of essential hypertension].
Topics: Adult; Aged; Clinical Trials as Topic; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Oxprenolol; Triamterene | 1980 |
3 other study(ies) available for triamterene and oxprenolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |